Phase I study of combination therapy with peptide vaccine and anti-cancer drug for colorectal cancer

Gan to kagaku ryoho. Cancer & chemotherapy

Volumn 35, Issue 12, 2008, Pages 2268-2270

  Yoshimatsu, Kazuhiko ^a   Yokomizo, Hajime ^a   Osawa, Gakuji ^a   Fujimoto, Takashi ^a   Otani, Taisuke ^a   Tsunoda, Takuya ^a   Nakamura, Yusuke ^a   Ogawa, Kenji ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CANCER VACCINE; DRUG DERIVATIVE; HLA A ANTIGEN; HLA A24 ANTIGEN; IRINOTECAN; OXONIC ACID; PEPTIDE; S 1 (COMBINATION); TEGAFUR; UNCLASSIFIED DRUG;

AGED; ARTICLE; CASE REPORT; CLINICAL TRIAL; COLORECTAL TUMOR; COMPUTER ASSISTED TOMOGRAPHY; DRUG COMBINATION; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; MALE; MULTIMODALITY CANCER THERAPY; PHASE 1 CLINICAL TRIAL; RADIOGRAPHY;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; CANCER VACCINES; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; DRUG COMBINATIONS; HLA-A ANTIGENS; HUMANS; IMMUNOTHERAPY; MALE; OXONIC ACID; PEPTIDES; TEGAFUR; TOMOGRAPHY, X-RAY COMPUTED;

EID: 58749109308     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)